Banerjee S, Le P, Yang H, Zhang L, He T
Stat Innov. 2025; 1.
PMID: 40052086
PMC: 11884733.
Quast N, Abanades B, Guloglu B, Karuppiah V, Harper S, Raybould M
Commun Biol. 2025; 8(1):362.
PMID: 40038394
PMC: 11880327.
DOI: 10.1038/s42003-025-07708-6.
Charette M, Rosenblum C, Shade O, Deiters A
Chem Rev. 2025; 125(4):1663-1717.
PMID: 39928721
PMC: 11869211.
DOI: 10.1021/acs.chemrev.4c00224.
Zhang W, Cao X
Front Immunol. 2025; 15():1515715.
PMID: 39845962
PMC: 11750696.
DOI: 10.3389/fimmu.2024.1515715.
Garitaonaindia Y, Martinez-Cutillas M, Uribarren M, Redondo I, Calvo V, Serna-Blasco R
Clin Transl Oncol. 2025; .
PMID: 39789380
DOI: 10.1007/s12094-024-03834-5.
Timing consistency of T cell receptor activation in a stochastic model combining kinetic segregation and proofreading.
Prustel T, Meier-Schellersheim M
ArXiv. 2024; .
PMID: 39679270
PMC: 11643218.
Bayesian metamodeling of early T-cell antigen receptor signaling accounts for its nanoscale activation patterns.
Neve-Oz Y, Sherman E, Raveh B
Front Immunol. 2024; 15:1412221.
PMID: 39524449
PMC: 11543436.
DOI: 10.3389/fimmu.2024.1412221.
Evaluation of prognostic significance of histopathological characteristics and tumor-infiltrating lymphocytes for pancreatic cancer survival.
Corbaci K, Gurleyik M, Gonultas A, Aker F, Gul M, Tilki M
Sci Rep. 2024; 14(1):27392.
PMID: 39521901
PMC: 11550438.
DOI: 10.1038/s41598-024-79342-x.
Microenvironmental alkalization promotes the therapeutic effects of MSLN-CAR-T cells.
Wu M, Mao L, Zhai X, Liu J, Wang J, Li L
J Immunother Cancer. 2024; 12(10).
PMID: 39433427
PMC: 11499857.
DOI: 10.1136/jitc-2024-009510.
Novel immunotherapeutic approaches in gastric cancer.
Yang M, Lin W, Huang J, Mannucci A, Luo H
Precis Clin Med. 2024; 7(4):pbae020.
PMID: 39397869
PMC: 11467695.
DOI: 10.1093/pcmedi/pbae020.
HLA-transgenic mouse models to study autoimmune central nervous system diseases.
Pressley K, Schwegman L, Montes De Oca Arena M, Chase Huizar C, Zamvil S, Forsthuber T
Autoimmunity. 2024; 57(1):2387414.
PMID: 39167553
PMC: 11470778.
DOI: 10.1080/08916934.2024.2387414.
Mathematical models of TCR initial triggering.
Shi J, Yin W, Chen W
Front Immunol. 2024; 15:1411614.
PMID: 39091495
PMC: 11291225.
DOI: 10.3389/fimmu.2024.1411614.
Current status and perspectives of clinical trials for tumor-infiltrating lymphocyte therapy.
Zhang Y, Fu H, Zhao Q
Clin Transl Oncol. 2024; 27(2):466-472.
PMID: 39078471
DOI: 10.1007/s12094-024-03608-z.
Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP.
Su H, Yu C, Sun G, Wang B, Gao Y, Liu X
Biomol Biomed. 2024; 25(1):29-41.
PMID: 39036926
PMC: 11647261.
DOI: 10.17305/bb.2024.10833.
Mechanical control of antigen detection and discrimination by T and B cell receptors.
Rogers J, Bajur A, Salaita K, Spillane K
Biophys J. 2024; 123(15):2234-2255.
PMID: 38794795
PMC: 11331051.
DOI: 10.1016/j.bpj.2024.05.020.
The potential and promise for clinical application of adoptive T cell therapy in cancer.
Li Y, Zheng Y, Liu T, Liao C, Shen G, He Z
J Transl Med. 2024; 22(1):413.
PMID: 38693513
PMC: 11064426.
DOI: 10.1186/s12967-024-05206-7.
Computational prediction of protein interactions in single cells by proximity sequencing.
Xia J, Phan H, Vistain L, Chen M, Khan A, Tay S
PLoS Comput Biol. 2024; 20(3):e1011915.
PMID: 38483861
PMC: 10939233.
DOI: 10.1371/journal.pcbi.1011915.
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review).
Yu T, Jiang W, Wang Y, Zhou Y, Jiao J, Wu M
Int J Oncol. 2024; 64(4).
PMID: 38390935
PMC: 10919759.
DOI: 10.3892/ijo.2024.5628.
Multimodal probing of T-cell recognition with hexapod heterostructures.
Huang X, Meng L, Cao G, Prominski A, Hu Y, Yang C
Nat Methods. 2024; 21(5):857-867.
PMID: 38374262
PMC: 11723587.
DOI: 10.1038/s41592-023-02165-7.
Optical sensing and control of T cell signaling pathways.
Lee H, Lee S, Inn K, Seong J
Front Physiol. 2024; 14:1321996.
PMID: 38269062
PMC: 10806162.
DOI: 10.3389/fphys.2023.1321996.